Filing Flows › Neuraxis (NRXS) › Q3 2026
Neuraxis (NRXS) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 9, 2026
Neuraxis (NRXS) reported revenue of $2.0M for the third quarter 2026 (Q3 2026), +150% from a year earlier and +5% from the quarter before. Operating margin was -324.4%, net loss $6.5M (322.8% of revenue).
Neuraxis, Q3 2026: revenue $2.0M (+150% year over year), operating margin -324.4%, net loss $6.5M, operating cash flow −$2.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.0M | +5% | +150% |
| Operating profit | −$6.6M | — | — |
| Net earnings | −$6.5M | — | — |
| Operating cash flow | −$2.3M | — | — |
What changed
Revenue was $2.0M in Q3 2026, up 150% year over year and up 5% from the previous quarter.
Gross margin was 86.6%, up 3.3 points from Q3 2025. Operating costs exceeded revenue by $6.6M, an operating margin of -324.4%. Operating expenses grew 200% against revenue growth of 150%. The fastest-growing cost line was General & admin (+274%). The quarter ended with a net loss of $6.5M, wider than the previous quarter's $2.1M loss.
Operating cash flow was −$2.3M. Non-cash charges added back $17K of depreciation and amortization and $4.1M of share-based compensation. Working capital and other items added $203K.
Questions
What was Neuraxis' revenue in the third quarter 2026?
Neuraxis (NRXS) reported revenue of $2.0M for the third quarter 2026 (Q3 2026), +150% from a year earlier and +5% from the quarter before.
Was Neuraxis profitable in the third quarter 2026?
Operating loss was $6.6M (-324.4% of revenue) and net loss $6.5M.
Source: Neuraxis 10-Q on SEC EDGAR.